Covered recipient · General Payments record
DOMINIC RAJ
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2018–2022
$23,952.09
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $8,295.00 | 3 |
| Travel and Lodging | $836.16 | 3 |
| Food and Beverage | $247.41 | 4 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $7,857.46 | 6 |
| Fresenius Kabi USA, LLC | $1,470.00 | 1 |
| Amgen Inc. | $51.11 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.36 | 01/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939842173 | CMS |
| Amgen Inc. | $19.37 | 03/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939842177 | CMS |
| Amgen Inc. | $16.38 | 05/31/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939842175 | CMS |
| Fresenius Kabi USA, LLC | $1,470.00 | 04/30/2022 | Consulting Fee | Undisputed | 01/23/2026 | 961072245 | CMS |
| Novo Nordisk Inc | $840.00 | 11/30/2022 | Consulting Fee | Undisputed | 01/23/2026 | 898951177 | CMS |
| Novo Nordisk Inc | $5,985.00 | 12/01/2022 | Consulting Fee | Undisputed | 01/23/2026 | 898672711 | CMS |
| Novo Nordisk Inc | $196.30 | 12/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898771423 | CMS |
| Novo Nordisk Inc | $257.63 | 12/01/2022 | Travel and Lodging | Undisputed | 01/23/2026 | 899095451 | CMS |
| Novo Nordisk Inc | $276.88 | 12/01/2022 | Travel and Lodging | Undisputed | 01/23/2026 | 899452357 | CMS |
| Novo Nordisk Inc | $301.65 | 12/01/2022 | Travel and Lodging | Undisputed | 01/23/2026 | 899452359 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.